Methocarbamol Use in Parkinson's Disease

Introduction to Methocarbamol

• Methocarbamol should be avoided in patients with Parkinson's disease due to its central nervous system depressant effects that may worsen parkinsonian symptoms 1

Mechanism and Concerns

• Methocarbamol is a centrally acting skeletal muscle relaxant and sedative that does not act directly on skeletal muscle, with an unclear precise mechanism of action 2
• It can cause adverse effects including drowsiness, dizziness, and cardiovascular effects such as bradycardia and hypotension, which may exacerbate symptoms in Parkinson's disease patients 2, 3

Specific Contraindications

• Methocarbamol is specifically noted to interfere with the effects of pyridostigmine bromide, a medication that may be used in some neurological conditions 2, 4
• The FDA notes that methocarbamol should not be used in patients with myasthenia gravis, suggesting caution with other neurological disorders like Parkinson's disease 4

Important Considerations

• Anticholinergic side effects from medications can be particularly problematic in Parkinson's disease patients, potentially worsening cognitive symptoms 1